Outlook Therapeutics, Inc. (OTLK) — DEF 14A Filings
All DEF 14A filings from Outlook Therapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Outlook Therapeutics Files Definitive Proxy Statement
— Feb 10, 2025 Risk: low
Outlook Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) on February 10, 2025, for its annual meeting on March 11, 2025. The company, formerly kn -
Outlook Therapeutics Files Definitive Proxy Statement
— Jun 26, 2024 Risk: medium
Outlook Therapeutics, Inc. filed its definitive proxy statement on June 26, 2024, for its annual meeting of stockholders scheduled for August 12, 2024. The fili -
Outlook Therapeutics Announces 2024 Annual Meeting of Stockholders
— Feb 8, 2024 Risk: medium
Outlook Therapeutics, Inc. (OTLK) filed a Proxy Statement (DEF 14A) with the SEC on February 8, 2024. Annual Meeting of Stockholders scheduled for March 7, 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX